Sinovac blazes vaccine trail in hand, foot and mouth disease
This article was originally published in Scrip
Executive Summary
Sinovac Biotech is planning to begin Phase II trials for what appears to be the most advanced vaccine worldwide for a serious form of hand, foot and mouth disease (HFMD), following promising initial clinical results with the inactivated product.